Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
2000 1
2002 2
2004 1
2005 2
2006 5
2007 5
2008 7
2009 5
2010 8
2011 13
2012 5
2013 12
2014 21
2015 31
2016 25
2017 22
2018 18
2019 24
2020 18
2021 16
2022 11
2023 13
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

176 results

Results by year

Filters applied: Meta-Analysis, Review, Systematic Review, in the last 10 years. Clear all
Page 1
Dengue Fever: Causes, Complications, and Vaccine Strategies.
Khetarpal N, Khanna I. Khetarpal N, et al. J Immunol Res. 2016;2016:6803098. doi: 10.1155/2016/6803098. Epub 2016 Jul 20. J Immunol Res. 2016. PMID: 27525287 Free PMC article. Review.
Recently, Sanofi Pasteur's chimeric live-attenuated dengue vaccine candidate has been approved in Mexico, Brazil, and Philippines for usage in adults between 9 and 45 years of age. ...Simultaneously, the restricted application of this vaccine candidate warrants cont …
Recently, Sanofi Pasteur's chimeric live-attenuated dengue vaccine candidate has been approved in Mexico, Brazil, and Philippi …
Dengue vaccine: an update.
Huang CH, Tsai YT, Wang SF, Wang WH, Chen YH. Huang CH, et al. Expert Rev Anti Infect Ther. 2021 Dec;19(12):1495-1502. doi: 10.1080/14787210.2021.1949983. Epub 2021 Jul 13. Expert Rev Anti Infect Ther. 2021. PMID: 34182875 Review.
Efficient vaccines for dengue prevention are currently lacking. This review aims to summarize the current progress in dengue vaccine development.Area covered: This article discusses recent dengue vaccine developments based on the published literature a …
Efficient vaccines for dengue prevention are currently lacking. This review aims to summarize the current progress in dengue vacci …
Dengue vaccine development: challenges and prospects.
Wilder-Smith A. Wilder-Smith A. Curr Opin Infect Dis. 2022 Oct 1;35(5):390-396. doi: 10.1097/QCO.0000000000000871. Curr Opin Infect Dis. 2022. PMID: 36098260 Review.
PURPOSE OF REVIEW: Dengue vaccine development is a high public health priority. To date, no dengue vaccine is in widespread use. ...SUMMARY: Although dengue-primed individuals can already benefit from vaccination with the first licensed dengue …
PURPOSE OF REVIEW: Dengue vaccine development is a high public health priority. To date, no dengue vaccine is in …
Dengue vaccine development: status and future.
Wilder-Smith A. Wilder-Smith A. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Jan;63(1):40-44. doi: 10.1007/s00103-019-03060-3. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020. PMID: 31784763 Free PMC article. Review.
Dengue, the most common arbovirus, represents an increasingly significant cause of morbidity worldwide, including in travelers. After decades of research, the first dengue vaccine was licensed in 2015: CYD-TDV, a tetravalent live attenuated vaccine with a yellow fev …
Dengue, the most common arbovirus, represents an increasingly significant cause of morbidity worldwide, including in travelers. After decade …
Updates on Dengue Vaccine and Antiviral: Where Are We Heading?
Norshidah H, Vignesh R, Lai NS. Norshidah H, et al. Molecules. 2021 Nov 9;26(22):6768. doi: 10.3390/molecules26226768. Molecules. 2021. PMID: 34833860 Free PMC article. Review.
Furthermore, in the aftermath of the only FDA-approved vaccine, Dengvaxia, a safer and more effective dengue vaccine candidate is making its way through the clinical trials. ...In this article, we highlighted recent advances made in the perspectives of efforts made …
Furthermore, in the aftermath of the only FDA-approved vaccine, Dengvaxia, a safer and more effective dengue vaccine candidate …
Is new dengue vaccine efficacy data a relief or cause for concern?
Thomas SJ. Thomas SJ. NPJ Vaccines. 2023 Apr 15;8(1):55. doi: 10.1038/s41541-023-00658-2. NPJ Vaccines. 2023. PMID: 37061527 Free PMC article. Review.
Recently, clinical efficacy data has been revealed for two additional dengue vaccine candidates and the data appears encouraging. In this perspective I discuss dengue, the complexities of dengue vaccine development, early development setbacks, and how …
Recently, clinical efficacy data has been revealed for two additional dengue vaccine candidates and the data appears encouragi …
A dengue vaccine whirlwind update.
Kariyawasam R, Lachman M, Mansuri S, Chakrabarti S, Boggild AK. Kariyawasam R, et al. Ther Adv Infect Dis. 2023 Apr 20;10:20499361231167274. doi: 10.1177/20499361231167274. eCollection 2023 Jan-Dec. Ther Adv Infect Dis. 2023. PMID: 37114191 Free PMC article. Review.
Insights into dengue immunity from vaccine trials.
Ooi EE, Kalimuddin S. Ooi EE, et al. Sci Transl Med. 2023 Jul 12;15(704):eadh3067. doi: 10.1126/scitranslmed.adh3067. Epub 2023 Jul 12. Sci Transl Med. 2023. PMID: 37437017 Review.
The quest for an effective dengue vaccine has culminated in two approved vaccines and another that has completed phase 3 clinical trials. ...Results from these trials suggest that neutralizing antibody titers alone are insufficient to inform protection against sympt …
The quest for an effective dengue vaccine has culminated in two approved vaccines and another that has completed phase 3 clini …
Dengue Tetravalent Vaccine, Live.
[No authors listed] [No authors listed] 2019 Oct 23. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2019 Oct 23. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 31369221 Free Books & Documents. Review.
Dengue vaccine is a live, attenuated vaccine indicated for children up to 16 years of age. ...If dengue vaccine is required by the mother, it is not a reason to discontinue breastfeeding....
Dengue vaccine is a live, attenuated vaccine indicated for children up to 16 years of age. ...If dengue vaccine …
Systematic review of dengue vaccine efficacy.
da Silveira LTC, Tura B, Santos M. da Silveira LTC, et al. BMC Infect Dis. 2019 Aug 28;19(1):750. doi: 10.1186/s12879-019-4369-5. BMC Infect Dis. 2019. PMID: 31455279 Free PMC article.
Vaccines for dengue are in various stages of development; in Brazil, only one commercial formulation is available (CYD-TDV), which was developed by Sanofi Pasteur. METHODS: To evaluate the efficacy of Dengue vaccine, a systematic review with a meta-analysis was cond …
Vaccines for dengue are in various stages of development; in Brazil, only one commercial formulation is available (CYD-TDV), which was devel …
176 results